felodipine+grapefruit

Can You Take felodipine and grapefruit Together?

Evidence-based clinical pharmacological assessment, adverse synergy evaluation, and administration separation protocols.

CRITICAL HAZARD: Potentially Severe or Contraindicated Combination

Co-administering felodipine and grapefruit has documented pharmacodynamic or pharmacokinetic antagonism capable of triggering acute clinical harm. Do not combine without explicit specialist oversight.

Clinical Mechanism & Evidence Details

Potassium-Enriched Salt Substitutes & High-Potassium SupplementsCRITICAL

Suppression of aldosterone causes renal potassium retention; potassium salt substitutes can trigger sudden, life-threatening hyperkalemic cardiac arrest.

Alcohol / EthanolHIGH

Alcohol may enhance gastrointestinal irritation, trigger orthostatic hypotension, or alter drug absorption kinetics.

Alcohol / EthanolHIGH

Alcohol may enhance gastrointestinal irritation, trigger orthostatic hypotension, or alter drug absorption kinetics.

MedlinePlus Dietary GuidanceMEDIUM

Talk to your doctor before using salt substitutes containing potassium. If your doctor prescribes a low-salt or low-sodium diet, follow these directions carefully.

Recommended Administration Timing Window
May form unabsorbable gastrointestinal chelates or compete for active mucosal transport. Separate administration by at least 2 to 4 hours.
Divalent iron cations bind this medication in the gut lumen, reducing systemic absorption. Separate by at least 2 to 3 hours.
Divalent iron cations bind this medication in the gut lumen, reducing systemic absorption. Separate by at least 2 to 3 hours.
Comprehensive Personal Stack Evaluation

Taking other supplements, foods, or medications with this pair?

Add your morning coffee, daily multivitamins, prescription pills, and dinner foods into our instant browser-based radar to check for multi-way chain reactions.

Launch SafeStack Radar with felodipine + grapefruit→
Authoritative Regulatory Citations

Clinical mechanism and interaction severity derived from openFDA Drug Structured Product Labeling (Section 7), NIH Office of Dietary Supplements (ODS), and NIH NCCIH clinical botanicals database.